{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:05:05Z","timestamp":1794899105383,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Hospitals Authority Youth Programme","award":["QMl220201802"],"award-info":[{"award-number":["QMl220201802"]}]},{"name":"Beijing Traditional Chinese medicine science and Technology Development Fund Project","award":["Qn-2020-25"],"award-info":[{"award-number":["Qn-2020-25"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["z181100001718052"],"award-info":[{"award-number":["z181100001718052"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver cirrhosis patients are at risk for esophagogastric variceal bleeding (EGVB). Herein, we aimed to estimate the EGVB risk in patients with liver cirrhosis using an artificial neural network (ANN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 999 liver cirrhosis patients hospitalized at the Beijing Ditan Hospital, Capital Medical University in the training cohort and 101 patients from Shuguang Hospital in the validation cohort. The factors independently affecting EGVB occurrence were determined via univariate analysis and used to develop an ANN model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 1-year cumulative EGVB incidence rates were 11.9 and 11.9% in the training and validation groups, respectively. A total of 12 independent risk factors, including gender, drinking and smoking history, decompensation, ascites, location and size of varices, alanine aminotransferase (ALT), \u03b3-glutamyl transferase (GGT), hematocrit (HCT) and neutrophil-lymphocyte ratio (NLR) levels as well as red blood cell (RBC) count were evaluated and used to establish the ANN model, which estimated the 1-year EGVB risk.<\/jats:p>\n                    <jats:p>\n                      The ANN model had an area under the curve (AUC) of 0.959, which was significantly higher than the AUC for the North Italian Endoscopic Club (NIEC) (0.669) and revised North Italian Endoscopic Club (Rev-NIEC) indices (0.725) (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001). Decision curve analyses revealed improved net benefits of the ANN compared to the NIEC and Rev-NIEC indices.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The ANN model accurately predicted the 1-year risk for EGVB in liver cirrhosis patients and might be used as a basis for risk-based EGVB surveillance strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-023-01293-0","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T04:03:58Z","timestamp":1677125038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Machine learning-based model for predicting the esophagogastric variceal bleeding risk in liver cirrhosis patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Yixin","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"1293_CR1","doi-asserted-by":"publisher","first-page":"e5904","DOI":"10.1097\/MD.0000000000005904","volume":"96","author":"P Golabi","year":"2017","unstructured":"Golabi P, Fazel S, Otgonsuren M, Sayiner M, Locklear CT, Younossi ZM. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore). 2017;96:e5904.","journal-title":"Medicine (Baltimore)"},{"key":"1293_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13651820410024058","volume":"7","author":"F Pons","year":"2005","unstructured":"Pons F, Varela M, Llovet JM. Staging systems in hepatocellular carcinoma. HPB (Oxford). 2005;7:35\u201341.","journal-title":"HPB (Oxford)"},{"key":"1293_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1293_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1080\/17474124.2018.1530986","volume":"12","author":"LZ Liu","year":"2018","unstructured":"Liu LZ, Sun J, Hou J, Chan HLY. Improvements in the management of chronic hepatitis B virus infection. Expert Rev Gastroenterol Hepatol. 2018;12:1153\u201366.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1293_CR5","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","volume":"62","author":"GV Papatheodoridis","year":"2015","unstructured":"Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol. 2015;62:956\u201367.","journal-title":"J Hepatol"},{"key":"1293_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/jgh.14534","volume":"34","author":"HLY Chan","year":"2019","unstructured":"Chan HLY. Okuda lecture: challenges of hepatitis B in the era of antiviral therapy. J Gastroenterol Hepatol. 2019;34:501\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"1293_CR7","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/hep.29320","volume":"66","author":"GV Papatheodoridis","year":"2017","unstructured":"Papatheodoridis GV, Idilman R, Dalekos GN, Buti M, Chi H, van Boemmel F, et al. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology. 2017;66:1444\u201353.","journal-title":"Hepatology"},{"key":"1293_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052\u201390.","journal-title":"Lancet"},{"key":"1293_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrgastro.2016.193","volume":"14","author":"G Sapisochin","year":"2017","unstructured":"Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14:203\u201317.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1293_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/gastro\/goz009","volume":"7","author":"LL He","year":"2019","unstructured":"He LL, Liu XL, Zhang S, Li MG, Wang XB, Jiang YY, et al. Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma \u22643 cm in diameter. Gastroenterol Rep (Oxf). 2019;7:250\u20137.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"1293_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jhep.2018.10.022","volume":"70","author":"G Marasco","year":"2019","unstructured":"Marasco G, Colecchia A, Colli A, Ravaioli F, Casazza G, Bacchi Reggiani ML, et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. J Hepatol. 2019;70:440\u20138.","journal-title":"J Hepatol"},{"key":"1293_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ajg.2011.425","volume":"107","author":"S Shiina","year":"2012","unstructured":"Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569\u201377.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1293_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","volume":"50","author":"MF Yuen","year":"2009","unstructured":"Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50(1):80\u20138.","journal-title":"J Hepatol"},{"key":"1293_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1053\/j.gastro.2013.02.002","volume":"144","author":"GL Wong","year":"2013","unstructured":"Wong GL, Chan HL, Chan HY, Tse PC, Tse YK, Mak CW, et al. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment. Gastroenterology. 2013;144:933\u201344.","journal-title":"Gastroenterology"},{"key":"1293_CR15","doi-asserted-by":"crossref","unstructured":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988;319(15):983\u20139.","DOI":"10.1056\/NEJM198810133191505"},{"key":"1293_CR16","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1111\/j.1572-0241.2000.03204.x","volume":"95","author":"C Merkel","year":"2000","unstructured":"Merkel C, Zoli M, Siringo S, van Buuren H, Magalotti D, Angeli P, et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the north Italian endoscopic Club (NIEC) index. Am J Gastroenterol. 2000;95:2915\u201320.","journal-title":"Am J Gastroenterol"},{"key":"1293_CR17","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198538493.001.0001","volume-title":"Neural networks for pattern recognition","author":"CM Bishop","year":"1995","unstructured":"Bishop CM. Neural networks for pattern recognition. New York: Oxford University Press; 1995."},{"key":"1293_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2478\/v10136-012-0031-x","volume":"11","author":"F Amato","year":"2013","unstructured":"Amato F, L\u00f3pez A, Pe\u00f1a-M\u00e9ndez EM, Va\u0148hara P, Hampl A, Havel J. Artificial neural networks in medical diagnosis. J Appl Biomed. 2013;11:47\u201358.","journal-title":"J Appl Biomed"},{"key":"1293_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2147\/TCRM.S257218","volume":"16","author":"R-Y Mai","year":"2020","unstructured":"Mai R-Y, Zeng J, Mo Y-S, Liang R, Lin Y, Wu S-S, et al. Artificial neural network model for liver cirrhosis diagnosis in patients with hepatitis B virus-related hepatocellular carcinoma. Ther Clin Risk Manag. 2020;16:639\u201349.","journal-title":"Ther Clin Risk Manag"},{"key":"1293_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12876-020-01191-5","volume":"20","author":"Y Hou","year":"2020","unstructured":"Hou Y, Zhang Q, Gao F, Mao D, Li J, Gong Z, et al. Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure. BMC Gastroenterol. 2020;20:75.","journal-title":"BMC Gastroenterol"},{"key":"1293_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.surg.2020.06.031","volume":"168","author":"R-y Mai","year":"2020","unstructured":"Mai R-y, Lu H-z, Bai T, Liang R, Lin Y, Ma L, et al. Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Surgery. 2020;168:643\u201352.","journal-title":"Surgery"},{"key":"1293_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/gastro\/goaa035","volume":"9","author":"Y-S Chen","year":"2020","unstructured":"Chen Y-S, Chen D, Shen C, Chen M, Jin C-H, Xu C-F, et al. A novel model for predicting fatty liver disease by means of an artificial neural network. Gastroenterol Rep (Oxf). 2020;9:31\u20137.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"1293_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fped.2020.00409","volume":"8","author":"J Liu","year":"2020","unstructured":"Liu J, Dai S, Chen G, Sun S, Jiang J, Zheng S, et al. Diagnostic value and effectiveness of an artificial neural network in biliary atresia. Front Pediatr. 2020;8:409.","journal-title":"Front Pediatr"},{"key":"1293_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646\u20139.","journal-title":"Br J Surg"},{"key":"1293_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464\u201370.","journal-title":"Hepatology"},{"key":"1293_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"EASL-EORTC clinical practice guidelines","year":"2012","unstructured":"EASL-EORTC clinical practice guidelines. Management of hepatocellular carcinoma. J Hepatol. 2012;56:908\u201343.","journal-title":"J Hepatol"},{"key":"1293_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261\u201383.","journal-title":"Hepatology"},{"key":"1293_CR28","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/hep.28895","volume":"65","author":"O Atiq","year":"2017","unstructured":"Atiq O, Tiro J, Yopp AC, Muffler A, Marrero JA, Parikh ND, et al. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatology. 2017;65:1196\u2013205.","journal-title":"Hepatology"},{"key":"1293_CR29","doi-asserted-by":"publisher","first-page":"f5334","DOI":"10.1136\/bmj.f5334","volume":"347","author":"B Heleno","year":"2013","unstructured":"Heleno B, Thomsen MF, Rodrigues DS, J\u00f8rgensen KJ, Brodersen J. Quantification of harms in cancer screening trials: literature review. BMJ. 2013;347:f5334.","journal-title":"BMJ"},{"key":"1293_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u201352.","journal-title":"J Hepatol"},{"key":"1293_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/00365520600930826","volume":"42","author":"F Tacke","year":"2007","unstructured":"Tacke F, Fiedler K, Trautwein C. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand J Gastroenterol. 2007;42:374\u201382.","journal-title":"Scand J Gastroenterol"},{"key":"1293_CR32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/0016-5085(91)70021-O","volume":"100","author":"G Kleber","year":"1991","unstructured":"Kleber G, Sauerbruch T, Ansari H, Paumgartner G. Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology. 1991;100:1332\u20137.","journal-title":"Gastroenterology"},{"key":"1293_CR33","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3904\/kjim.2018.120","volume":"34","author":"BH Kim","year":"2019","unstructured":"Kim BH, Chung JW, Lee CS, Jang ES, Jeong SH, Kim N, et al. Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis. Korean J Intern Med. 2019;34:1233\u201343.","journal-title":"Korean J Intern Med"},{"key":"1293_CR34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1440-1746.2004.03383.x","volume":"19","author":"DK Park","year":"2004","unstructured":"Park DK, Um SH, Lee JW, Lee JB, Kim YS, Park CH, et al. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices. J Gastroenterol Hepatol. 2004;19:1042\u201351.","journal-title":"J Gastroenterol Hepatol"},{"key":"1293_CR35","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.3748\/wjg.v24.i26.2902","volume":"24","author":"I Aggeletopoulou","year":"2018","unstructured":"Aggeletopoulou I, Konstantakis C, Manolakopoulos S, Triantos C. Role of band ligation for secondary prophylaxis of variceal bleeding. World J Gastroenterol. 2018;24:2902\u201314.","journal-title":"World J Gastroenterol"},{"key":"1293_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/BF00295980","volume":"15","author":"HJ Voerman","year":"1989","unstructured":"Voerman HJ, Groeneveld AB. Blood viscosity and circulatory shock. Intensive Care Med. 1989;15:72\u20138.","journal-title":"Intensive Care Med"},{"key":"1293_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2169\/internalmedicine1962.27.155","volume":"27","author":"I Ohki","year":"1988","unstructured":"Ohki I, Dan K, Kuriya S, Nomura T. A study on the mechanism of anemia and leukopenia in liver cirrhosis. Jpn J Med. 1988;27:155\u20139.","journal-title":"Jpn J Med"},{"key":"1293_CR38","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1440-1746.2006.04266.x","volume":"21","author":"TT Liu","year":"2006","unstructured":"Liu TT, Wong WJ, Hou MC, Lin HC, Chang FY, Lee SD. Hemorheology in patients with liver cirrhosis: special emphasis on its relation to severity of esophageal variceal bleeding. J Gastroenterol Hepatol. 2006;21:908\u201313.","journal-title":"J Gastroenterol Hepatol"},{"key":"1293_CR39","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/MEG.0000000000000943","volume":"29","author":"YJ Zhou","year":"2017","unstructured":"Zhou YJ, Zheng JN, Zhou YF, Han YJ, Zou TT, Liu WY, et al. Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol. 2017;29:1166\u201373.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-023-01293-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-023-01293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T10:33:00Z","timestamp":1701945180000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-023-01293-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1293"],"URL":"https:\/\/doi.org\/10.1186\/s13000-023-01293-0","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of our hospital (approval number: 2020\u2013043-02), because of its retrospective nature and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}